References
- 1. Saenger P, Czernichow P, Hughes I, Reiter EO: Small for gestational age: short stature and beyond. Endocr Rev 2007; 28(2): 219–251.10.1210/er.2006-0039
- 2. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rappaport R, Rogol A: Management of the child born small for gestational age through to adulthood: a con-sensus statement of the International Societies of Paediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 2007; 92(3): 804-810.10.1210/jc.2006-2017
- 3. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P: International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Paediatrics 2003; 111(6 Pt 1): 1253-1261.
- 4. Jancevska A, Tasic V, Damcevski N, Danilovski D, Jovanovska V, Gucev Z. Children born small for gestational age (SGA). Prilozi 2012; 33(2): 47-58.
- 5. Hamilton BE, Martin JA, Ventura SJ, Sutton BD, Menacker F. Biths: preliminary data for 2004. Natl Vital Stat Rep 2005; 54: 1-17.
- 6. Fujita K, Nagasaka M, Iwatani S, Koda T, Kurokawa D, Yamana K, Nishida K, Tanigu-chi-Ikeda M, Uchino E, Shirai C, Iijima K, Morioka I. Prevalence of small for gestate-onal age (SGA) infants and short children born SGA who qualify for growth hormone treatment at 3 years of age: A population-based study. Pediatr Int. 2015 Nov 30.
- 7. Hwang IT. Efficacy and safety of growth hormone treatment for children born small for gestational age. Korean J Pediatr. 2014; 57(9): 379–383.
- 8. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestate-onal age with and without catch-up growth. Acta Paediatr Suppl 1994; 399: 64-70.
- 9. Black RE. Global Prevalence of Small for Gestational Age Births. Nestle Nutr Inst Workshop Ser. 2015; 81: 1-7.
- 10. Argente J, Mehls O, Barrios V. Growth and body composition in very young SGA children. Pediatr Nephrol 2010; 25(4): 679-685.
- 11. Albertsson-Wikland K, Boguszewski M, Karl-berg J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res. 1998; 49 Suppl 2: 7-13.10.1159/000053080
- 12. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF et al. Obesity. Nat Rev Dis Primers 2017; 15 (3): 1-18.
- 13. Blankenstein O, Snajderova M, Blair J, Pour-nara E, PedersenBT, Petit IO. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study. Eur J Endocrinol. 2017; 177(2): 145-155.
- 14. Jung H, Rosilio M, Blum WF, Drop SL. Growth hormone treatment for short stature in children born small for gestational age. Adv Ther 2008; 25(10): 951-78.
- 15. Azcona C, Albanese A, Bareille P, Stanhope R. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome. Horm Res 1998; 50(1): 22-27.
- 16. Schwarz HP, Birkholz-Walerzak D, Szalecki M, Walczak M, Galesanu C, Metreveli D. et al. One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age. Biol Ther. 2014 Jan 28.
- 17. Lee PA, Sävendahl L, Oliver I, Tauber M, Blankenstein O, Ross J et al. Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observational studies. Int J Pediatr Endocrinol 2012; 2012(1): 22.
- 18. Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, Welch K, Bryant J. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess 2010; 14(42): 1-209.
- 19. Luo ZC, Albertsson-Wikland K, Karlberg J. Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age. Paediatrics. 1998; 102(6): E72.
- 20. Aurensanz Clemente E, Samper Villagrasa P, Ayerza Casas A, Ruiz Frontera P, Bueno Lozano O, Moreno Aznar LA et al. Effects of growth hormone treatment on anthropometrics, metabolic risk, and body composition variables in small for gestational age patients. An Pediatr (Barc). 2017; 86(5): 240-248.
- 21. Boguszewski MC, Mericq V, Bergada I, Damiani D, Belgorosky A, Gunczler P et al. Latin American consensus: children born small for gestational age. BMC Pediatr 2011; 11: 66.
- 22. De Schepper J, Vanderfaeillie J, Mullis PE, Rooman R, Robertson A, Dilleen M, Gomez R, Wollmann HA. A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin (®)) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study. Clin Endocrinol (Oxf). 2016; 84(3): 353-60.10.1111/cen.12968
- 23. Tauber M. Final height and intrauterine growth retardation. Ann Endocrinol (Paris) 2017; 78(2): 96-97.
- 24. Laron Z, Laron-Kenet T, Klinger G. For Debate: Growth Hormone Treatment of Infants Born Small for Gestational Age should be started at or before the First Year of Age. Pediatr Endocrinol Rev. 2016; 14(2): 105-108.
- 25. Zanelli SA, Rogol AD. Short children born small for gestational age outcomes in the era of growth hormone therapy. Growth Horm IGF Res. 2018; 38: 8-13.10.1016/j.ghir.2017.12.013
- 26. Yüksel B, Özbek MN, Mungan NÖ, Darendeliler F, Budan B, Bideci A et al. Serum IGF-1 and IG-FBP-3 levels in healthy children between 0 and 6 years of age. J Clin Res Pediatr Endocrinol. 2011; 3(2): 84-8.
- 27. Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, et al. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Horm Res 2005; 64(2): 68-76.
- 28. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996; 81(11): 3902-3908.
- 29. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, et al. IGF-I receptor mutations resulting in postnatal growth retardation intrauterine and. N Engl J Med 2003; 349 (23): 2211-22.
- 30. Okubo Y, Siddle K, Firth H, O’Rahilly S, Wilson LC, Willatt L et al. Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 2003; 88: 5981-5988.
- 31. Raile K, Klammt J, Schneider A, Keller A, Laue S, Smith R et al. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab 2006; 91: 2264-2271.
- 32. Walenkamp MJ, de Muinck Keizer-Schrama SM, de Mos M, Kalf ME, van Duyvenvoorde HA, Boot AM et al. Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. J Clin Endocrinol Metab 2008; 93: 2421-2425.
- 33. Juanes M, Guercio G, Marino R, Berensztein E, Warman DM, Ciaccio M et al. Three novel IGF1R mutations in microcephalic patients with prenatal and postnatal growth impairment. Clin Endocrinol (Oxf) 2015; 82(5): 704-711.